Ductal carcinoma in situ is a precursor of breast cancer that is usually treated with surgery, radiation therapy, and estrogen blockade. A new study suggests that watchful waiting might be safe for ...

A biopsy reveals squamous cell carcinoma (SCC) in situ. What should be the next steps in the patient's evaluation and management? After the initial consultation, the patient's biopsy specimen was ...

BOSTON & MONTREAL, January 31, 2025--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage genetic ...

aCancer Research UK, Centre for Epidemiology, Mathematics, and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary School of Medicine and Dentistry, University of London, London, UK ...

Danielle Fishel, star actress in Boy Meets World, recently opened up about her experience with ductal carcinoma in situ (DCIS), a non-invasive breast cancer. While celebrating the completion of her ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

Adenocarcinoma: A type of cancer that forms ... cells from the original tumor site to other parts of the body. In situ hybridization: A laboratory technique used to detect specific nucleic acid ...

They are able to invade nearby tissues and spread throughout the body, often evading the immune system. Intraductal carcinoma (also called ductal carcinoma in situ) is when there is cancer in the milk ...

The Program Committee of the AUA has accepted the Theralase®'s abstract titled: ' Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive ...

Share on Pinterest “Boy Meets World” actor Danielle Fishel recently completed treatment for a very early stage of breast cancer known as ductal carcinoma in situ (DCIS). Paul Archuleta/Getty ...

ImmunityBio (IBRX) announced the European Medicines Agency has accepted for review and begun assessing the marketing authorization application ...

ImmunityBio IBRX shares rallied 27.2% on Thursday after it announced that it has completed the regulatory filing process in the EU and the United Kingdom for Anktiva (nogapendekin alfa inbakicept) in ...